 |
|
|
| |
GS-5816, a Second-Generation HCV NS5A Inhibitor With Potent Antiviral Activity, Broad Genotypic Coverage, and a High Resistance Barrier
|
| |
| |
Reported by Jules Levin
EASL 2013 April 28 Amsterdam
Guofeng Cheng, Yang Tian, Mei Yu, Yu-Jen Lee, Ruoyu Gong, Alejandra Trejo-Martin, Betty Peng, Margaret Robinson, Rudolf Beran, Caroline Bush, Katie Chan,
Michelle Nash, Angela Worth, Huiling Yang, Jason Perry, James Taylor, Chris Yang, Matthew Paulson, William Delaney IV, John O. Link
Gilead Sciences, Inc., Foster City, CA, USA
|
| |
|
|
|
|
|
